> top > docs > PubMed:26212080 > annotations

PubMed:26212080 JSONTXT

Annnotations TAB JSON ListView MergeView

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
26212080-0#0#13#gene10099 0-13 gene10099 denotes Tetraspanin 3
26212080-0#65#91#diseaseC0023467 65-91 diseaseC0023467 denotes Acute Myelogenous Leukemia
26212080-3#52#71#gene84549 412-431 gene84549 denotes RNA binding protein
26212080-3#52#71#gene56902 412-431 gene56902 denotes RNA binding protein
26212080-3#52#71#gene5725 412-431 gene5725 denotes RNA binding protein
26212080-3#52#71#gene27303 412-431 gene27303 denotes RNA binding protein
26212080-3#52#71#gene23524 412-431 gene23524 denotes RNA binding protein
26212080-3#72#81#gene124540 432-441 gene124540 denotes Musashi 2
26212080-3#109#112#diseaseC0023467 469-472 diseaseC0023467 denotes AML
26212080-3#109#112#diseaseC0023467 469-472 diseaseC0023467 denotes AML
26212080-5#9#15#gene10099 555-561 gene10099 denotes Tspan3
26212080-5#34#52#diseaseC0280141 580-598 diseaseC0280141 denotes leukemia stem cell
26212080-5#34#52#diseaseC1378511 580-598 diseaseC1378511 denotes leukemia stem cell
26212080-7#79#85#gene6387 900-906 gene6387 denotes CXCL12
26212080-7#86#91#gene6387 907-912 gene6387 denotes SDF-1
26212080-7#114#117#diseaseC0023467 935-938 diseaseC0023467 denotes AML
26212080-8#15#21#gene10099 985-991 gene10099 denotes Tspan3
26212080-8#97#103#gene10099 1067-1073 gene10099 denotes Tspan3
26212080-8#62#71#diseaseC0023418 1032-1041 diseaseC0023418 denotes leukemias
26212080-8#107#118#diseaseC0596263 1077-1088 diseaseC0596263 denotes oncogenesis
26212080-8#62#71#diseaseC0023418 1032-1041 diseaseC0023418 denotes leukemias
26212080-8#107#118#diseaseC0596263 1077-1088 diseaseC0596263 denotes oncogenesis
0#13#gene1009965#91#diseaseC0023467 26212080-0#0#13#gene10099 26212080-0#65#91#diseaseC0023467 associated_with Tetraspanin 3,Acute Myelogenous Leukemia
52#71#gene84549109#112#diseaseC0023467 26212080-3#52#71#gene84549 26212080-3#109#112#diseaseC0023467 associated_with RNA binding protein,AML
52#71#gene84549109#112#diseaseC0023467 26212080-3#52#71#gene84549 26212080-3#109#112#diseaseC0023467 associated_with RNA binding protein,AML
52#71#gene56902109#112#diseaseC0023467 26212080-3#52#71#gene56902 26212080-3#109#112#diseaseC0023467 associated_with RNA binding protein,AML
52#71#gene56902109#112#diseaseC0023467 26212080-3#52#71#gene56902 26212080-3#109#112#diseaseC0023467 associated_with RNA binding protein,AML
52#71#gene5725109#112#diseaseC0023467 26212080-3#52#71#gene5725 26212080-3#109#112#diseaseC0023467 associated_with RNA binding protein,AML
52#71#gene5725109#112#diseaseC0023467 26212080-3#52#71#gene5725 26212080-3#109#112#diseaseC0023467 associated_with RNA binding protein,AML
52#71#gene27303109#112#diseaseC0023467 26212080-3#52#71#gene27303 26212080-3#109#112#diseaseC0023467 associated_with RNA binding protein,AML
52#71#gene27303109#112#diseaseC0023467 26212080-3#52#71#gene27303 26212080-3#109#112#diseaseC0023467 associated_with RNA binding protein,AML
52#71#gene23524109#112#diseaseC0023467 26212080-3#52#71#gene23524 26212080-3#109#112#diseaseC0023467 associated_with RNA binding protein,AML
52#71#gene23524109#112#diseaseC0023467 26212080-3#52#71#gene23524 26212080-3#109#112#diseaseC0023467 associated_with RNA binding protein,AML
72#81#gene124540109#112#diseaseC0023467 26212080-3#72#81#gene124540 26212080-3#109#112#diseaseC0023467 associated_with Musashi 2,AML
72#81#gene124540109#112#diseaseC0023467 26212080-3#72#81#gene124540 26212080-3#109#112#diseaseC0023467 associated_with Musashi 2,AML
9#15#gene1009934#52#diseaseC0280141 26212080-5#9#15#gene10099 26212080-5#34#52#diseaseC0280141 associated_with Tspan3,leukemia stem cell
9#15#gene1009934#52#diseaseC1378511 26212080-5#9#15#gene10099 26212080-5#34#52#diseaseC1378511 associated_with Tspan3,leukemia stem cell
79#85#gene6387114#117#diseaseC0023467 26212080-7#79#85#gene6387 26212080-7#114#117#diseaseC0023467 associated_with CXCL12,AML
86#91#gene6387114#117#diseaseC0023467 26212080-7#86#91#gene6387 26212080-7#114#117#diseaseC0023467 associated_with SDF-1,AML
15#21#gene1009962#71#diseaseC0023418 26212080-8#15#21#gene10099 26212080-8#62#71#diseaseC0023418 associated_with Tspan3,leukemias
15#21#gene10099107#118#diseaseC0596263 26212080-8#15#21#gene10099 26212080-8#107#118#diseaseC0596263 associated_with Tspan3,oncogenesis
15#21#gene1009962#71#diseaseC0023418 26212080-8#15#21#gene10099 26212080-8#62#71#diseaseC0023418 associated_with Tspan3,leukemias
15#21#gene10099107#118#diseaseC0596263 26212080-8#15#21#gene10099 26212080-8#107#118#diseaseC0596263 associated_with Tspan3,oncogenesis
97#103#gene1009962#71#diseaseC0023418 26212080-8#97#103#gene10099 26212080-8#62#71#diseaseC0023418 associated_with Tspan3,leukemias
97#103#gene10099107#118#diseaseC0596263 26212080-8#97#103#gene10099 26212080-8#107#118#diseaseC0596263 associated_with Tspan3,oncogenesis
97#103#gene1009962#71#diseaseC0023418 26212080-8#97#103#gene10099 26212080-8#62#71#diseaseC0023418 associated_with Tspan3,leukemias
97#103#gene10099107#118#diseaseC0596263 26212080-8#97#103#gene10099 26212080-8#107#118#diseaseC0596263 associated_with Tspan3,oncogenesis

DisGeNet-2017-sample

Id Subject Object Predicate Lexical cue
T1603 412-431 gene:84549 denotes RNA binding protein
T1604 469-472 disease:C0023467 denotes AML
R1 T1603 T1604 associated_with RNA binding protein,AML
R2 T1603 T1604 associated_with RNA binding protein,AML
R3 T1603 T1604 associated_with RNA binding protein,AML
R4 T1603 T1604 associated_with RNA binding protein,AML
R5 T1603 T1604 associated_with RNA binding protein,AML

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-92 Sentence denotes Tetraspanin 3 Is Required for the Development and Propagation of Acute Myelogenous Leukemia.
TextSentencer_T2 93-227 Sentence denotes Acute Myelogenous Leukemia (AML) is an aggressive cancer that strikes both adults and children and is frequently resistant to therapy.
TextSentencer_T3 228-359 Sentence denotes Thus, identifying signals needed for AML propagation is a critical step toward developing new approaches for treating this disease.
TextSentencer_T4 360-473 Sentence denotes Here, we show that Tetraspanin 3 is a target of the RNA binding protein Musashi 2, which plays a key role in AML.
TextSentencer_T5 474-545 Sentence denotes We generated Tspan3 knockout mice that were born without overt defects.
TextSentencer_T6 546-690 Sentence denotes However, Tspan3 deletion impaired leukemia stem cell self-renewal and disease propagation and markedly improved survival in mouse models of AML.
TextSentencer_T7 691-820 Sentence denotes Additionally, Tspan3 inhibition blocked growth of AML patient samples, suggesting that Tspan3 is also important in human disease.
TextSentencer_T8 821-969 Sentence denotes As part of the mechanism, we show that Tspan3 deficiency disabled responses to CXCL12/SDF-1 and led to defects in AML localization within the niche.
TextSentencer_T9 970-1089 Sentence denotes These identify Tspan3 as an important regulator of aggressive leukemias and highlight a role for Tspan3 in oncogenesis.
T1 0-92 Sentence denotes Tetraspanin 3 Is Required for the Development and Propagation of Acute Myelogenous Leukemia.
T2 93-227 Sentence denotes Acute Myelogenous Leukemia (AML) is an aggressive cancer that strikes both adults and children and is frequently resistant to therapy.
T3 228-359 Sentence denotes Thus, identifying signals needed for AML propagation is a critical step toward developing new approaches for treating this disease.
T4 360-473 Sentence denotes Here, we show that Tetraspanin 3 is a target of the RNA binding protein Musashi 2, which plays a key role in AML.
T5 474-545 Sentence denotes We generated Tspan3 knockout mice that were born without overt defects.
T6 546-690 Sentence denotes However, Tspan3 deletion impaired leukemia stem cell self-renewal and disease propagation and markedly improved survival in mouse models of AML.
T7 691-820 Sentence denotes Additionally, Tspan3 inhibition blocked growth of AML patient samples, suggesting that Tspan3 is also important in human disease.
T8 821-969 Sentence denotes As part of the mechanism, we show that Tspan3 deficiency disabled responses to CXCL12/SDF-1 and led to defects in AML localization within the niche.
T9 970-1089 Sentence denotes These identify Tspan3 as an important regulator of aggressive leukemias and highlight a role for Tspan3 in oncogenesis.